Talos Table 1: complete evaluation cohort outcomes
Table 1 in final 2026 article · Peer-reviewed
What this source contributed
Records in this release that cite this source. A record can cite several sources.
Results
Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.
Claims
Statements this source supports, each with where in the source it was checked.
- Evidence summary: unresolved rare-disease reanalysis: Summary No study gives two reanalysis methods the same updated information and compares their new diagnoses, so this evidence cannot show which method finds more. One preprint compares methods on the same unresolved cases: in Kaschta et al. 2026, manual expert reanalysis and the automated tool Talos were applied to 219 genomes without a prior pathogenic or likely pathogenic finding. The arms had unequal inputs: the manual arm re-called the original reads with a newer DRAGEN version while Talos used the archived calls, and Talos was scored against the manual findings, so findings only Talos might have made were not counted. Each arm added the same three pathogenic or likely pathogenic cases, taking the cohort from 158 to 161 of 377 cases (42.7%), and manual reanalysis classified two new VUS cases, one of which Talos returned. Manual review took a mean of 81 minutes per case and Talos returned about three variants per case on average, but no analyst time was printed for reviewing the Talos output, so the two effort figures cannot be compared. The numbers are small, from one centre with a high initial yield, and Illumina, which makes the manual arm's software, supported the study. The other printed comparisons measure review workload, or recovery of diagnoses that were already known. In the Solve-RD CNV reanalysis of unsolved exomes, three callers returned different numbers of calls for expert review: ExomeDepth 4205, ClinCNV 2782 and CoNIFER 862. These counts overlap where callers found the same CNV, thresholds differ by caller, and ClinCNV was developed by the study's first author. In 100,000 Genomes Project cases diagnosed after a new disease-gene association, the Exomiser developers' recommended flagging rule (phenotype score increase 0.2, variant score 0.8) flagged 31 of the 37 diagnostic variants and 23 other variants, while the loosest rule tested flagged all 37 and 182 others; the rules were chosen on these same cases. In the Talos developers' ACG trio cohort, strict phenotype filtering returned 403 candidate variants instead of 487 and recovered 164 known diagnoses instead of 177. The known diagnoses come from each cohort's earlier analysis, and Talos recovery counts only diagnoses its own calling pipeline could detect. Recall on known diagnoses is not new diagnostic yield, each comparison was reported by the developers of at least one method compared, and none is clinical validation. (rare-reanalysis-20261009-source-demidov2024: Table 1; rare-reanalysis-20261009-source-vestito2024-supp: Exomiser threshold table; uc-clinical-20260930-source-talos-table1: Table 1; reanalysis-kaschta-20261010-source-kaschta2026: Results and Methods)
- Published study membership: Exomiser rank-budget recovery in ACG trios: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos diagnosis recovery and workload: ACG full: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos diagnosis recovery and workload: ACG singleton: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos diagnosis recovery and workload: ACG trio: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos diagnosis recovery and workload: RGP full: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos diagnosis recovery and workload: RGP singleton: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos diagnosis recovery and workload: RGP trio: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos programme reanalysis yield: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Relevance of Talos default versus strict filtering on known diagnoses, ACG full (Talos 2026 Table 1) to "Reanalyse unresolved rare-disease cases": Assessed by Talos diagnosis recovery and workload: ACG full (uc-clinical-20260930-source-talos-table1: Table 1, ACG full columns; uc-clinical-20260930-source-talos: Results; Table 1)
- Relevance of Talos default versus strict filtering on known diagnoses, ACG singleton (Talos 2026 Table 1) to "Reanalyse unresolved rare-disease cases": Assessed by Talos diagnosis recovery and workload: ACG singleton (uc-clinical-20260930-source-talos-table1: Table 1, ACG singleton columns; uc-clinical-20260930-source-talos: Results; Table 1)
- Relevance of Talos default versus strict filtering on known diagnoses, ACG trio (Talos 2026 Table 1) to "Reanalyse unresolved rare-disease cases": Assessed by Talos diagnosis recovery and workload: ACG trio (uc-clinical-20260930-source-talos-table1: Table 1, ACG trio columns; uc-clinical-20260930-source-talos: Results; Table 1)
- Relevance of Talos default versus strict filtering on known diagnoses, RGP full (Talos 2026 Table 1) to "Reanalyse unresolved rare-disease cases": Assessed by Talos diagnosis recovery and workload: RGP full (uc-clinical-20260930-source-talos-table1: Table 1, RGP full columns; uc-clinical-20260930-source-talos: Results; Table 1)
- Relevance of Talos default versus strict filtering on known diagnoses, RGP singleton (Talos 2026 Table 1) to "Reanalyse unresolved rare-disease cases": Assessed by Talos diagnosis recovery and workload: RGP singleton (uc-clinical-20260930-source-talos-table1: Table 1, RGP singleton columns; uc-clinical-20260930-source-talos: Results; Table 1)
- Relevance of Talos default versus strict filtering on known diagnoses, RGP trio (Talos 2026 Table 1) to "Reanalyse unresolved rare-disease cases": Assessed by Talos diagnosis recovery and workload: RGP trio (uc-clinical-20260930-source-talos-table1: Table 1, RGP trio columns; uc-clinical-20260930-source-talos: Results; Table 1)
- Relevance of Talos diagnosis recovery and workload: ACG full to "Rank rare-disease variants for review": Assessed by Talos diagnosis recovery and workload: ACG full (uc-clinical-20260930-source-talos-table1: Table 1, ACG, full)
- Relevance of Talos diagnosis recovery and workload: ACG singleton to "Rank rare-disease variants for review": Assessed by Talos diagnosis recovery and workload: ACG singleton (uc-clinical-20260930-source-talos-table1: Table 1, ACG, singleton)
- Relevance of Talos diagnosis recovery and workload: ACG trio to "Rank rare-disease variants for review": Assessed by Talos diagnosis recovery and workload: ACG trio (uc-clinical-20260930-source-talos-table1: Table 1, ACG, trio)
- Relevance of Talos diagnosis recovery and workload: RGP full to "Rank rare-disease variants for review": Assessed by Talos diagnosis recovery and workload: RGP full (uc-clinical-20260930-source-talos-table1: Table 1, RGP, full)
- Relevance of Talos diagnosis recovery and workload: RGP singleton to "Rank rare-disease variants for review": Assessed by Talos diagnosis recovery and workload: RGP singleton (uc-clinical-20260930-source-talos-table1: Table 1, RGP, singleton)
- Relevance of Talos diagnosis recovery and workload: RGP trio to "Rank rare-disease variants for review": Assessed by Talos diagnosis recovery and workload: RGP trio (uc-clinical-20260930-source-talos-table1: Table 1, RGP, trio)
Models, benchmarks and other records
Benchmarks (1)
Protocols (6)
Datasets (6)
Baselines (1)
Evaluations (12)
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
16 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Artifact retrieved at 2026-09-30T21:25:04Z Source metadata | Talos Table 1: complete evaluation cohort outcomes No field-specific location recorded Version: Table 1 in final 2026 article | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Artifact SHA-256 cb86e1a542f458271efdf67464b12faf246ee2f78419e565afe8b87158e77e5b Source metadata | Talos Table 1: complete evaluation cohort outcomes No field-specific location recorded Version: Table 1 in final 2026 article | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Artifact url https://www.nature.com/articles/s41591-026-04477-5/tables/1 Source metadata | Talos Table 1: complete evaluation cohort outcomes No field-specific location recorded Version: Table 1 in final 2026 article | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Doi 10.1038/s41591-026-04477-5 Source metadata | Talos Table 1: complete evaluation cohort outcomes No field-specific location recorded Version: Table 1 in final 2026 article | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Publication status peer_reviewed Source metadata | Talos Table 1: complete evaluation cohort outcomes No field-specific location recorded Version: Table 1 in final 2026 article | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Retrieved at 2026-09-30T21:43:37Z Source metadata | Talos Table 1: complete evaluation cohort outcomes No field-specific location recorded Version: Table 1 in final 2026 article | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Url https://www.nature.com/articles/s41591-026-04477-5/tables/1 Source metadata | Talos Table 1: complete evaluation cohort outcomes No field-specific location recorded Version: Table 1 in final 2026 article | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Version Table 1 in final 2026 article Source metadata | Talos Table 1: complete evaluation cohort outcomes No field-specific location recorded Version: Table 1 in final 2026 article | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Description Primary source inspected for the scoped extraction; automated review does not establish replication. Source metadata | Talos Table 1: complete evaluation cohort outcomes No field-specific location recorded Version: Table 1 in final 2026 article | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Facets: areas1 values
| Talos Table 1: complete evaluation cohort outcomes No field-specific location recorded Version: Table 1 in final 2026 article | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
Primary source inspected for the scoped extraction; automated review does not establish replication.
Technical metadata and extraction receipts
Stable ID: uc-clinical-20260930-source-talos-table1
- areas
- dna-genomes
- contexts
- clinical_research
- url
- https://www.nature.com/articles/s41591-026-04477-5/tables/1
- retrieved at
- 2026-09-30T21:43:37Z
- version
- Table 1 in final 2026 article
- publication status
- peer_reviewed
- doi
- 10.1038/s41591-026-04477-5
- artifact sha256
- cb86e1a542f458271efdf67464b12faf246ee2f78419e565afe8b87158e77e5b
- artifact url
- https://www.nature.com/articles/s41591-026-04477-5/tables/1
- artifact retrieved at
- 2026-09-30T21:25:04Z